tiprankstipranks
Immunovant, Inc. (IMVT)
NASDAQ:IMVT
US Market
IMVT
Immunovant
RESEARCH TOOLSreports
Want to see IMVT full AI Analyst Report?

Immunovant (IMVT) Financial Statements

942 Followers

Immunovant Financial Overview

Immunovant's market cap is currently $7.24B. The company's EPS TTM is $-2.69; its P/E ratio is -10.43; Immunovant is scheduled to report earnings on May 20, 2026, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ 0.00$ -438.15M$ -270.21M$ -208.28M$ -156.03M
EBITDA$ 0.00$ -437.77M$ -269.98M$ -208.08M$ -155.91M
Net Income$ -505.61M$ -413.84M$ -259.34M$ -210.96M$ -156.73M
Balance Sheet
Cash & Short-Term Investments$ 902.11M$ 713.97M$ 635.37M$ 376.53M$ 493.82M
Total Assets$ 957.01M$ 776.22M$ 666.71M$ 405.84M$ 515.56M
Total Debt$ 72.00K$ 98.00K$ 138.00K$ 1.22M$ 2.36M
Net Debt$ -902.04M$ -713.87M$ -635.23M$ -375.31M$ -491.45M
Total Liabilities$ 104.42M$ 68.78M$ 48.95M$ 43.34M$ 45.74M
Stockholders' Equity$ 852.59M$ 707.45M$ 617.76M$ 362.49M$ 469.82M
Cash Flow
Free Cash Flow$ -407.32M$ -376.63M$ -214.59M$ -188.39M$ -106.37M
Operating Cash Flow$ -407.31M$ -375.87M$ -214.23M$ -188.19M$ -106.11M
Investing Cash Flow$ -8.00K$ -759.00K$ -360.00K$ -197.00K$ -254.00K
Financing Cash Flow$ 595.76M$ 454.49M$ 472.43M$ 70.89M$ 200.13M
Currency in USD

Immunovant Earnings and Revenue History

Income Statement >

Immunovant Debt to Assets

Balance Sheet >

Immunovant Cash Flow

Cash Flow >

Immunovant Forecast EPS vs Actual EPS

Earnings >